Universität zu Köln

Journal Article

Bobrowicz, Malgorzata ORCID: 0000-0002-9078-5168, Dwojak, Michal, Pyrzynska, Beata ORCID: 0000-0002-0490-618X, Stachura, Joanna, Muchowicz, Angelika ORCID: 0000-0003-4707-1722, Berthel, Elise, Dalla-Venezia, Nicole, Kozikowski, Mieszko, Siernicka, Marta, Miazek, Nina, Zapala, Piotr, Domagala, Antoni, Bojarczuk, Kamil ORCID: 0000-0002-6110-4060, Malenda, Agata ORCID: 0000-0002-3444-2718, Barankiewicz, Joanna ORCID: 0000-0002-5029-9173, Graczyk-Jarzynka, Agnieszka ORCID: 0000-0001-7980-0542, Zagozdzon, Agnieszka, Gabrysiak, Magdalena, Diaz, Jean-Jacques, Karp, Marta ORCID: 0000-0003-1108-1961, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Firczuk, Malgorzata ORCID: 0000-0002-1719-5233, Giannopoulos, Krzysztof ORCID: 0000-0003-0135-4030, Efremov, Dimitar G., Laurenti, Luca ORCID: 0000-0002-8327-1396, Baatout, Dunja, Frenzel, Lukas, Malinowska, Agata ORCID: 0000-0001-6599-901X, Slabicki, Mikolaj, Zenz, Thorsten, Zerrouqi, Abdessamad ORCID: 0000-0002-2628-473X, Golab, Jakub ORCID: 0000-0002-2830-5100 and Winiarska, Magdalena (2017). HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies. Blood, 130 (14). S. 1628 - 1639. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Robak, Tadeusz, Hellmann, Andrzej, Kloczko, Janusz, Loscertales, Javier, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Pagel, John M., Mato, Anthony, Byrd, John C., Awan, Farrukh T., Hebart, Holger, Garcia-Marco, Jose A., Hill, Brian T., Hallek, Michael, Eisenfeld, Amy J., Stromatt, Scott C. and Jaeger, Ulrich (2017). Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia. Br. J. Haematol., 176 (4). S. 618 - 629. HOBOKEN: WILEY. ISSN 1365-2141

Robak, Tadeusz, Hellman, Andrzej, Loscertales, Javier, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Pagel, John M., Mato, Anthony R., Byrd, John C., Awan, Farrukh ORCID: 0000-0003-1813-9812, Hebart, Holger, Garcia-Marco, Jose A., Hill, Brian T., Hallek, Michael, Stromatt, Scott and Kloczko, Janusz (2014). Phase 2 Study of Otlertuzumab (TRU-016), an Anti-CD37 ADAPTIR (TM) Protein, in Combination with Bendamustine Vs Bendamustine Alone in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) - Updated Results. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020